Rebeca Ortega

411 total citations
8 papers, 325 citations indexed

About

Rebeca Ortega is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Rebeca Ortega has authored 8 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 5 papers in Hematology and 4 papers in Molecular Biology. Recurrent topics in Rebeca Ortega's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Acute Myeloid Leukemia Research (3 papers) and Extracellular vesicles in disease (2 papers). Rebeca Ortega is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers), Acute Myeloid Leukemia Research (3 papers) and Extracellular vesicles in disease (2 papers). Rebeca Ortega collaborates with scholars based in Spain. Rebeca Ortega's co-authors include Fermín Sánchez‐Guijo, Sandra Muntión, Concepción Rodríguez, Consuelo del Cañizo, Silvia Preciado, Ángel Hernández‐Hernández, Alba Redondo, Luis Ignacio Sánchez‐Abarca, Teresa Lopes Ramos and Guillermo López-Ruano and has published in prestigious journals such as Blood, PLoS ONE and British Journal of Haematology.

In The Last Decade

Rebeca Ortega

8 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rebeca Ortega Spain	6	201	123	99	41	37	8	325
Silvia Preciado Spain	9	284 1.4×	198 1.6×	154 1.6×	50 1.2×	73 2.0×	16	452
Yimeng Wei China	6	125 0.6×	131 1.1×	77 0.8×	50 1.2×	36 1.0×	6	287
Linglin Zou China	8	174 0.9×	59 0.5×	127 1.3×	47 1.1×	20 0.5×	16	313
Shing-Jyh Chang Taiwan	6	230 1.1×	138 1.1×	133 1.3×	101 2.5×	14 0.4×	6	417
Roberta Carusone Italy	4	302 1.5×	194 1.6×	162 1.6×	55 1.3×	62 1.7×	8	439
Sarah Hemming Australia	7	375 1.9×	85 0.7×	113 1.1×	20 0.5×	15 0.4×	7	456
Rafael Contreras‐López France	8	112 0.6×	176 1.4×	51 0.5×	56 1.4×	23 0.6×	12	325
Antonietta Fazio Italy	10	216 1.1×	139 1.1×	48 0.5×	56 1.4×	36 1.0×	23	458
Jinping Bai China	9	170 0.8×	245 2.0×	57 0.6×	122 3.0×	15 0.4×	13	403
Jon Fernández‐Rueda Spain	8	159 0.8×	139 1.1×	64 0.6×	56 1.4×	25 0.7×	8	339

Countries citing papers authored by Rebeca Ortega

Since Specialization

Citations

This map shows the geographic impact of Rebeca Ortega's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebeca Ortega with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebeca Ortega more than expected).

Fields of papers citing papers by Rebeca Ortega

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebeca Ortega. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebeca Ortega. The network helps show where Rebeca Ortega may publish in the future.

Co-authorship network of co-authors of Rebeca Ortega

This figure shows the co-authorship network connecting the top 25 collaborators of Rebeca Ortega. A scholar is included among the top collaborators of Rebeca Ortega based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebeca Ortega. Rebeca Ortega is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Ortega, Rebeca, Catalina Falo, Silvia Vázquez, et al.. (2023). 11P Independent validation of the HER2DX assay in HER2-positive (HER2+) breast cancer (BC) treated with neoadjuvant paclitaxel, trastuzumab and pertuzumab (THP): A correlative analysis from the BiOnHER study. ESMO Open. 8(1). 101235–101235. 1 indexed citations

Jiménez, Tamara, Irene Aires‐Mejía, Rebeca Ortega, et al.. (2019). Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity. British Journal of Haematology. 187(1). 93–104. 15 indexed citations

Sánchez‐Abarca, Luis Ignacio, Beatriz Rosón, Alba Redondo, et al.. (2017). Mesenchymal stromal cells (MSC) from JAK2+ myeloproliferative neoplasms differ from normal MSC and contribute to the maintenance of neoplastic hematopoiesis. PLoS ONE. 12(8). e0182470–e0182470. 15 indexed citations

Preciado, Silvia, Sandra Muntión, Ana Isabel Rico, et al.. (2017). Mesenchymal Stromal Cell Irradiation Interferes with the Adipogenic/Osteogenic Differentiation Balance and Improves Their Hematopoietic-Supporting Ability. Biology of Blood and Marrow Transplantation. 24(3). 443–451. 16 indexed citations

Ramos, Teresa Lopes, Luis Ignacio Sánchez‐Abarca, Alba Redondo, et al.. (2017). HDAC8 overexpression in mesenchymal stromal cells from JAK2+ myeloproliferative neoplasms: a new therapeutic target?. Oncotarget. 8(17). 28187–28202. 10 indexed citations

Ramos, Teresa Lopes, Luis Ignacio Sánchez‐Abarca, Sandra Muntión, et al.. (2016). MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry. Cell Communication and Signaling. 14(1). 2–2. 246 indexed citations

Ramos, Teresa Lopes, Luis Ignacio Sánchez‐Abarca, Beatriz Rosón, et al.. (2016). Extracellular Vesicles Play an Important Role in Intercellular Communication Between Bone Marrow Stroma and Hematopoietic Progenitor Cells in Myeloproliferative Neoplasms. Blood. 128(22). 1957–1957. 5 indexed citations

González, Beatriz, Rebeca Ortega, Marta Martínez‐Júlvez, et al.. (2012). NADP+ Binding to the Regulatory Subunit of Methionine Adenosyltransferase II Increases Intersubunit Binding Affinity in the Hetero-Trimer. PLoS ONE. 7(11). e50329–e50329. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact